Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 98422T100
Event date: 2025-06-30
- Filing-level shares
- 10,613,944
- Percent of class
- 19.9%
- GILEAD SCIENCES, INC.
Shares: 10,613,944 · Class: 19.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001123292-25-000366
- Form type
- SCHEDULE 13G/A
- Filer
- GILEAD SCIENCES, INC.
- CIK
- CIK 882095
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership